Add
WST to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| WST > SEC Filings for WST > Form 8-K on 19-Sep-2012 | All Recent SEC Filings |
19-Sep-2012
Regulation FD Disclosure, Financial Statements and Exhibits
On September 19, 2012, our management will present at the UBS 2012 Global Life Sciences Conference in New York, New York at 4:00 PM Eastern Time.
A copy of the Company's presentation materials from the conference will be available for 30 days through the Investors link at the Company's website, http://www.westpharma.com, and is also attached hereto as Exhibit 99.1 and incorporated herein by reference.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (Exchange Act) or otherwise subject to the liabilities of that section, nor will it be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing.
(d) Exhibits
Exhibit 99.1 West Pharmaceutical Services, Inc. Overview (Investor Presentation).
|
|